Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Prioritize Hydration GLP-1s can sometimes cause dehydration and constipation
Keeping objective and subjective notes side by side is what makes an end-of-cycle review meaningful
A Medicare GLP-1 Bridge program covering Wegovy and Zepbound under Part D at a reported $50/month copay is expected to begin July 2026
Trial participants had a variety of cancers, including biliary tract, bladder, cervical, pancreatic and certain rare tumors
So your prescriber can help match you with the option that best fits your needs: Ozempic: Approved for Type 2 diabetes and to lower the risk of serious cardiovascular and kidney-related problems in certain people Wegovy: Approved for weight loss and to lower the risk of serious cardiovascular problems if you have heart disease and a larger body size Mounjaro: Approved for Type 2 diabetes Zepbound : Approved for weight loss and moderate-to-severe obstructive sleep apnea (OSA) Be prepared to share details about your current compounded GLP-1 prescription
US$ 23.01
US$ 21.55
US$ 20.00
US$ 25.00
US$ 29.04
